title: Protamine dosing--the quandary continues.
authors.forename: R I
authors.initials: RI
authors.lastname: Hall
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology; D001803:Blood Transfusion; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D004347:Drug Interactions; D016903:Drug Monitoring; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology; D006494:Heparin Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D019106:Postoperative Hemorrhage / Q000517:prevention & control; D011479:Protamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D012680:Sensitivity and Specificity; D013997:Time Factors; D017186:Titrimetry; D014914:Whole Blood Coagulation Time
chemical_list: D000925:Anticoagulants; D006494:Heparin Antagonists; D011479:Protamines; D006493:Heparin